Clinical Trials Browser

Stage III Lung Non-Small Cell Cancer AJCC v7

Carcinoma, Uterine Cervical Neoplasms

Neoplasms, Germ Cell and Embryonal, Recurrence

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Pancreatic Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

Carcinoma, Non-Small-Cell Lung

Small Cell Lung Carcinoma

Triple Negative Breast Neoplasms

Neoplasm Metastasis

Glioblastoma

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Esophageal Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

Neuroendocrine Tumors

Parkinson Disease 4, Autosomal Dominant Lewy Body, Triple Negative Breast Neoplasms

Squamous Cell Carcinoma of Head and Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma

Carcinoma, Non-Small-Cell Lung

Lung Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Parkinson Disease 4, Autosomal Dominant Lewy Body

Carcinoma, Non-Small-Cell Lung

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

Carcinoma, Non-Small-Cell Lung

Endometrial Neoplasms

Clinical Trials

Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy for Stage III Non-small Cell Lung Cancer

BEATcc

TICE

Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors

Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer

SKYSCRAPER-02

NeoSACT

A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors

Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy

HIPEC

PROTECT

Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery

Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer

KEYLYNK-009

Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer

Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)

KEYLYNK-008

Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)

AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer

Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer

Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer

Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer

LEAP-006

MK-7684A-007

KEYNOTE-826

SKYSCRAPER-06

LEAP-001